Clinical Trial Update: TMC278-TiDP6-C209: A Clinical Trial in Treatment Naive HIV-1 Patients Comparing TMC278 to Efavirenz in Combination With Tenofovir + Emtricitabine. [Phase 3]

View source ↗

Summary

Phase 3 trial in treatment-naive HIV-1 patients compares rilpivirine (TMC278) to efavirenz, both with tenofovir/emtricitabine; results were posted after complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Edurant (rilpivirine) (rilpivirine)
• Emtriva (emtricitabine) (emtricitabine)
• Sustiva (efavirenz) (efavirenz)
• Viread (Tenofovir disoproxil fumarate) (Tenofovir disoproxil fumarate)

Snippet

Sponsor: Tibotec Pharmaceuticals, Ireland | Conditions: HIV Infections, HIV-1 | Phase 3 | Status: COMPLETED | Results posted: 2011-07-11